Cargando…
Safety and efficacy of ibrutinib in a patient with severe renal impairment
Autores principales: | Filanovsky, Kalman, Shvidel, Lev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Scientific Publications, Pavia, Italy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641823/ https://www.ncbi.nlm.nih.gov/pubmed/29071051 http://dx.doi.org/10.4081/hr.2017.7078 |
Ejemplares similares
-
Managing Ibrutinib-Intolerant Patients With B-Cell
Malignancies
por: Muñoz, Javier, et al.
Publicado: (2023) -
Efficacy and safety of combination therapies vs monotherapy of hypomethylating agents in accelerated or blast phase of Philadelphia negative myeloproliferative neoplasms: a systematic review and meta-analysis
por: Chen, Jia, et al.
Publicado: (2023) -
The correlation between fibroblast growth factor-23 and ESRD patients with hearing impairment
por: Nie, Jingwen, et al.
Publicado: (2021) -
Study of Arterial Blood Gas Analysis in Moderate-to-Severe COVID-19 Patients
por: Sanghani, Hiren, et al.
Publicado: (2022) -
Severe hyperferremia and hyperferritinemia in a dog with precursor‐directed immune‐mediated anemia
por: Zersen, Kristin M., et al.
Publicado: (2022)